Chemical Compound

XL-147|||N-[3-(2,1,3-Benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

CAS Registry Number 956958-53-5
XL-147|||N-[3-(2,1,3-Benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide 结构式
Primary record

XL-147|||N-[3-(2,1,3-Benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

库存
4,538 克
纯度
98.2 %
CAS
956958-53-5

化合物标识与属性

CAS
956958-53-5
PubChem CID
1893730
SMILES
CC1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4
Canonical SMILES
Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1

名称与同义词

  • XL147
  • Pilaralisib analogue
  • Pilaralisib
  • 956958-53-5
  • XL147 analogue
  • PI3K inhibitor X
  • XL147-II
  • XL-147
  • XL-147 derivative 2
  • XL147 derivative II
  • Exelixis pI3K inhibitor
  • RefChem:934334
  • MFCD16621245
  • SAR245408
  • XL 147
  • cc-43
  • D02IZS
  • D03KAC
  • AC1LZ6F0
  • AC1Q2LO8
  • C21H16N6O2S2
  • Oprea1_361507
  • ZSTK474
  • CHEBI:71957
  • GTPL7963
  • orb1305574
  • SCHEMBL1792641
  • N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
  • CHEMBL3218575
  • AOB5431
  • DTXSID10145779
  • SYN1127
  • XL147 analogue(PI3K inhibitor X)
  • GLXC-06312
  • HMS3654E06
  • BCP01861
  • EX-A1362
  • ZINC2267166
  • ABP000084
  • AN-530
  • NSC754351
  • NSC755806
  • NSC801009
  • RW3070
  • s1118
  • STL325024
  • XL147/XL-147
  • ZINC02267166
  • AKOS015842552
  • AKOS022131419
  • ACN-037797
  • CCG-269221
  • CID1893730
  • CS-0088
  • NSC-754351
  • NSC-755806
  • NSC-801009
  • PB33271
  • QC-1903
  • RL06023
  • SAR-245408
  • SDCCGSBI-0654346.P001
  • NCGC00346492-01
  • NCGC00346492-09
  • AC-23168
  • BC660050
  • HY-11105
  • MS-28126
  • SC-85909
  • SY259599
  • AB0008192
  • A5112
  • FT-0662582
  • N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide
  • SW219812-1
  • X7417
  • 1033110-57-4
  • EC-000.2364
  • J3.553.988C
  • N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide
  • SAR245408 + MSC1936369B
  • A10995
  • A20590
  • Q-4583
  • N-[3-(2
  • BRD-K95901403-001-01-1
  • BRD-K95901403-001-04-5
  • N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxali
  • Q27088392
  • Pilaralisib analog (XL147 analog, SAR245408 analog)
  • B0084-258924
  • N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide,
  • XL 147, XL-147, 956958-53-5
  • Benzenesulfonamide, N-[3-(2,1,3-benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methyl-
  • N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methyl-benzenesulfonamide
  • N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methyl-benzenesulfonamide
  • N-{3-[(2,1,3-Benzothiadiazol-5-yl)amino]quinoxalin-2-yl}-4-methylbenzene-1-sulfonamide
  • N-(3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide
  • N-[3-(2,1,3-benzothiadiazol-6-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
  • N-[3-(Benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
  • XL-147|||N-[3-(2,1,3-Benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide